HLF
HerbalifeCNYSE / Household & Personal Products
Last Price
At close
2026-06-02
Current thesis
The bull case is that Q1 2026 came in above guidance, full-year midpoint guidance was raised, refinancing should lower interest burden, and Bioniq adds another growth lever if rollout and distributor adoption scale.
Posture
Mixed
Lead driver
Sentiment
What changed
2 setup hits (3d) with net bearish as of 2026-06-02.
What can break
Bioniq adoption and rollout execution are early-stage and could disappoint.
Momentum
11
Value
72
Sentiment
74
Setup hits (3d)
2 · Net Bearish
AI TargetsBase $15.50 · Bull $19.00 · Bear $10.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-19 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bearish
Target $17.00
Why
Momentum11 · Δ7d -7.8
Value72 · Δ7d +0.5
Sentiment74 · Δ7d +9.0
So what
Balanced signals (Net Bearish). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
11
34% active weight
Current posture
7d trendSoftening
Δ7d
-7.8
Δ21d
-74.4
Value
72
32% active weight
Current posture
7d trendFlat
Δ7d
+0.5
Δ21d
+1.0
Sentiment
74
33% active weight
Current posture
7d trendImproving
Δ7d
+9.0
Δ21d
+25.4
Why this grade
Composite grade C. Momentum 10.6 / Value 71.7 / Sentiment 74.3
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.23B
Beta
0.84
Shares Out
103.31M
P/E (TTM)
4.1
P/S (TTM)
0.27
P/FCF (TTM)
6.15
Rev YoY
+2.7%
EPS YoY
-10.7%
Gross Margin
+78.0%
Op Margin
+9.8%
Net Debt
$1.84B
Current Ratio
1.11
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology